Log In
Print
BCIQ
Print
Print this Print this
 

Relday, risperidone

  Manage Alerts
Collapse Summary General Information
Company Zogenix Inc.
DescriptionZogenix's DosePro subcutaneous drug delivery system plus a subcutaneous once-monthly formulation of risperidone formulated using Durect's SABER controlled-release technology
Molecular Target
Mechanism of Action 
Latest Stage of DevelopmentPhase I
IndicationSchizophrenia
Partner

Durect Corp.
 Product Details
 Archive Items are loading loading
Get a free BioCentury trial today